MLMarcin Lewandowski

Marcin Lewandowski

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marcin Lewandowski has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Perception of Generic Drugs Among Pharmacists in Poland: The Role of Sociodemographic Factors in Shaping Professional Attitudes and Practices

    by Marcin Lewandowski, Urszula Religioni, Dariusz Świetlik, Adam Kobayashi, Marcin Czech, Piotr Wierzbiński, Daniel Śliż, Waldemar Wierzba, Katarzyna Plagens-Rotman, Piotr Merks

    Background: Pharmacists’ perceptions and practices shape the real-world uptake of generic medicines. From a health-economics perspective, wider generic substitution reduces patient out-of-pocket spending and creates headroom in payer budgets for high-value interventions. We assessed attitudes toward the efficacy, safety, and use of generics and examined sociodemographic correlates among Polish pharmacists. Methods: Analytical cross-sectional survey of licensed pharmacists in Poland was used (June–August 2025). The questionnaire covered reasons for recommending generics in long-term and single-use therapy; doubts about efficacy; views on bioequivalence testing; patient-reported experiences; and Likert-scale opinions on innovation, safety, efficacy, access, and payer savings. Associations were tested with χ2 and Mann–Whitney U (α = 0.05). Results: Of 342 respondents (67.5% women; 74.9% community pharmacists), cost was the leading reason to recommend generics in long-term therapy (91.0%), followed by efficacy (53.0%) and safety (51.5%); for single-use prescriptions, cost remained central (76.2%), with lower emphasis on efficacy (47.5%) and safety (45.0%). Pharmacists who never recommend generics were older and more experienced (p = 0.006; p = 0.012). Doubts about generic efficacy were reported by 36.2% overall and more often among women, hospital pharmacists, and those with a specialization; 53.5% of those with doubts would advise switching even to a costlier option. Nearly half supported conducting bioequivalence studies between generics (49.6%). Positive perceptions predominated: 82.9% agreed generics are as effective and 84.6% as safe as originators. Most endorsed system benefits, including payer savings enabling list expansion (73.6%) and improved patient access (92.5%); agreement on access was higher among community pharmacists (p = 0.004). Conclusions: Polish pharmacists largely view generics as clinically equivalent and system-enhancing, with cost the dominant driver of recommendation. Targeted education—especially for hospital settings and specialized pharmacists—and attention to patient-reported experiences may further strengthen confidence and appropriate use of generics.


  • Open Access

    Impact of COVID-19 Infection on Cardiorespiratory Fitness, Sleep, and Psychology of Endurance Athletes—CAESAR Study

    by Daniel Śliż, Szczepan Wiecha, Jakub S. Gąsior, Przemysław Seweryn Kasiak, Katarzyna Ulaszewska, Marcin Lewandowski, Marcin Barylski, Artur Mamcarz

    COVID-19 has a deteriorating impact on health which is especially important for endurance athletes (EAs) who need to maintain continuity of training. The illness affects sleep and psychology, which influence sport performance. The aims of this study were: (1) to assess the consequences of mild COVID-19 on sleep and psychology and (2) to assess the consequences of mild COVID-19 on cardiopulmonary exercise test (CPET) results. A total of 49 EAs (males = 43, 87.76%; females = 6, 12.24%; age = 39.9 ± 7.8 years; height = 178.4 ± 6.8 cm; weight = 76.3 ± 10.4 kg; BMI = 24.0 ± 2.6 kg·m−2) underwent a maximal cycling or running CPET pre- and post-COVID-19 and completed an original survey. Exercise performance deteriorated after COVID-19 (maximal oxygen uptake, VO2max = 47.81 ± 7.81 vs. 44.97 ± 7.00 mL·kg·min−1 pre- and post-infection, respectively; p < 0.001). Waking up at night affected the heart rate (HR) at the respiratory compensation point (RCP) (p = 0.028). Sleep time influenced pulmonary ventilation (p = 0.013), breathing frequency (p = 0.010), and blood lactate concentration (Lac) (p = 0.013) at the RCP. The maximal power/speed (p = 0.046) and HR (p = 0.070) were linked to the quality of sleep. Stress management and relaxation techniques were linked with VO2max (p = 0.046), maximal power/speed (p = 0.033), and maximal Lac (p = 0.045). Cardiorespiratory fitness deteriorated after mild COVID-19 and was correlated with sleep and psychological indices. Medical professionals should encourage EAs to maintain proper mental health and sleep after COVID-19 infection to facilitate recovery.


  • Open Access

    Validity of the Maximal Heart Rate Prediction Models among Runners and Cyclists

    by Przemysław Seweryn Kasiak, Szczepan Wiecha, Igor Cieśliński, Tim Takken, Jacek Lach, Marcin Lewandowski, Marcin Barylski, Artur Mamcarz, Daniel Śliż

    Maximal heart rate (HRmax) is a widely used measure of cardiorespiratory fitness. Prediction of HRmax is an alternative to cardiopulmonary exercise testing (CPET), but its accuracy among endurance athletes (EA) requires evaluation. This study aimed to externally validate HRmax prediction models in the EA independently for running and cycling CPET. A total of 4043 runners (age = 33.6 (8.1) years; 83.5% males; BMI = 23.7 (2.5) kg·m−2) and 1026 cyclists (age = 36.9 (9.0) years; 89.7% males; BMI = 24.0 (2.7) kg·m−2) underwent maximum CPET. Student t-test, mean absolute percentage error (MAPE), and root mean square error (RMSE) were applied to validate eight running and five cycling HRmax equations externally. HRmax was 184.6 (9.8) beats·min−1 and 182.7 (10.3) beats·min−1, respectively, for running and cycling, p = 0.001. Measured and predicted HRmax differed significantly (p = 0.001) for 9 of 13 (69.2%) models. HRmax was overestimated by eight (61.5%) and underestimated by five (38.5%) formulae. Overestimated HRmax amounted to 4.9 beats·min−1 and underestimated HRmax was in the range up to 4.9 beats·min−1. RMSE was 9.1–10.5. MAPE ranged to 4.7%. Prediction models allow for limited precision of HRmax estimation and present inaccuracies. HRmax was more often underestimated than overestimated. Predicted HRmax can be implemented for EA as a supplemental method, but CPET is the preferable method.